The value of conducting laboratory investigations on airway clearance devices

Respiratory Care

Volumn 53, Issue 3, 2008, Pages 311-313

  Volsko, Teresa A ^a  

^a YOUNGSTOWN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREATHING EXERCISE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PRACTICE; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE EXACERBATION; EDITORIAL; EXPIRATORY FLOW; HUMAN; LUNG CLEARANCE; MEDICAL TECHNOLOGY; OSCILLATION; PATIENT CARE PLANNING; PERFORMANCE; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY THERAPIST; THERAPY EFFECT; ARTIFICIAL VENTILATION; BREATHING DISORDER; CHEST WALL OSCILLATION; EQUIPMENT DESIGN; INSTRUMENTATION; MATERIALS TESTING; NOTE; PATHOPHYSIOLOGY;

CHEST WALL OSCILLATION; EQUIPMENT DESIGN; HUMANS; MATERIALS TESTING; POSITIVE-PRESSURE RESPIRATION; RESPIRATION DISORDERS; RESPIRATION, ARTIFICIAL;

EID: 44449164647     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Foster WM. Mucociliary transport and cough in humans. Pulm Pharmacol Ther 2002;15(3):277-282.
2. Hess DR. The evidence for secretion clearance techniques. Respir Care 2001;46(11):1276-1293.
3. McCool FD, Rosen MJ. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1-Suppl):250S-259S.
4. Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994;124(5 Pt 1):689-693.
5. Chatham K, Marshall C, Campbell IA, Prescott RJ. The Flutter VPR1 device for post-thoracotomy patients. Physiology 1993;79(2):95-98.
6. Homnick DN, Anderson K, Marks JH. Comparison of the flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis: a pilot study. Chest 1998;114(4):993-997.
7. Dasgupta B, Brown NE, King M. Effects of sputum oscillations and rhDNase in vitro; a combined approach to treat cystic fibrosis lung disease. Pediatr Pulmonol 1998;26(4):250-255.
8. Anonymous author(s). Nyquist rate. http://en.wikipedia.org/wiki/nyquist- rate. Accessed December 30, 2007.
9. App EM, Kieselmann R, Reinhardt D, Lindemann H, Dasgupta B, King M, Brand P. Sputum rheology changes in cystic fibrosis lung disease following 2 different types of physiotherapy: flutter vs autogenic drainage. Chest 1998;114(1):171-177.
10. Volsko TA, DiFiore J, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella vs Flutter. Respir Care 2003;48(2):124-130.
11. Alves LA, Pitta F, Brunetto AF. Performance analysis of the Flutter VRP1 under different flows and angles. Respir Care 2008;53(3):316-323.